Longitudinal analysis of taurine induced effects on the tear proteome of contact lens wearers and dry eye patients using a RP-RP-Capillary-HPLC-MALDI TOF/TOF MS approach

Journal of Proteomics

Volumn 75, Issue 11, 2012, Pages 3177-3190

  Funke, Sebastian ^a   Azimi, Diana ^a   Wolters, Dominik ^a   Grus, Franz H ^a   Pfeiffer, Norbert ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Contact lens; Dry eye; LC MALDI; Proteomics; Taurine; Tears

Indexed keywords

EYE DROPS; SODIUM CHLORIDE; TAURINE; TEAR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CAPILLARY CHROMATOGRAPHY; CLINICAL ARTICLE; CONTACT LENS; CONTROLLED STUDY; DRY EYE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONTACT LENS SOLUTIONS; CONTACT LENSES; DRY EYE SYNDROMES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TAURINE; TEARS; TIME FACTORS;

EID: 84861675757     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.03.018     Document Type: Article

References (83)

1. Farris R.L. Tear analysis in contact lens wearers. Trans Am Ophthalmol Soc 1985, 133:501-545.
2. Begley C.G., Caffery B., Nichols K.K., Chalmers R. Responses of contact lens wearers to a dry eye survey. Optom Vis Sci 2000, 77:40-46.
3. Guillon M., Maissa C. Dry eye symptomatology of soft contact lens wearers and nonwearers. Optom Vis Sci 2005, 82:9-834.
4. Holly F.J., Lemp M.A. Tear physiology and dry eyes. Surv Ophthalmol 1977, 22:69-87.
5. Nichols J.J., Sinnott L.T. Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye. Invest Ophthalmol Vis Sci 2006, 47:1319-1328.
6. Mathers W.D. Why the eye becomes dry: a cornea and lacrimal gland feedback model. CLAO J 2000, 26.
7. Grus F.H., Augustin A.J. Analysis of tear protein patterns by a neural network as a diagnostical tool for the detection of dry eyes. Electrophoresis 1999, 20:875-880.
8. Ohashi Y., Ishida R., Kojima T., Goto E., Matsumoto Y., Watanabe K., et al. Abnormal protein profiles in tears with dry eye syndrome. Am J Ophthalmol 2003, 136:291-299.
9. Grus F.H., Podust V.N., Bruns K., Lackner K., Fu S., Dalmasso E.A., et al. SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Invest Ophthalmol Vis Sci 2005, 46:863-875.
10. Caffery B., Joyce E., Boone E., Slomovic A., Simpson T., Jones L., et al. Tear lipocalin and lysozyme in Sjögren and non-Sjogren dry eye. Optom Vis Sci 2008, 85:661-667.
11. Zhou L., Beuerman R.W., Chan C.M., Zhao S.Z., Li X.R., Yang H., et al. Identification of tear fluid biomarkers in dry eye syndrome using ITRAQ quantitative proteomics. J Proteome Res 2009, 8:4889-4905.
12. Nichols J.J., Green-Church K. Mass spectrometry-based proteomic analyses in contact lens-related dry eye. Cornea 2009, 28:1109-1117.
13. Kramann C., Boehm N., Lorenz K., Wehrwein N., Stoffelns B.M., Pfeiffer N., et al. Effect of contact lenses on the protein composition in tear film: a ProteinChip study. Graefes Arch Clin Exp Ophthalmol 2011, 249:233-243.
14. Grus F.H., Sabuncuo P., Augustin A., Pfeiffer N. Effect of smoking on tear proteins. Graefes Arch Clin Exp Ophthalmol 2002, 240:889-892.
15. Foulks G. pharmacological management of dry eye in the elderly patient. Drugs Aging 2008, 25:105-118.
16. Wilson G., Riley M.V. Does topical hydrogen peroxide penetrate the cornea?. Invest Ophthalmol Vis Sci 1993, 34:2752-2760.
17. Faber E., Golding T.R., Lowe R., Brennan N.A. Effect of hydrogel lens wear on tear film stability. Optom Vis Sci 1991, 68:380-384.
18. Zhivov A., Stave J., Vollmar B., Guthoff R. In vivo confocal microscopic evaluation of Langerhans cell density and distribution in the corneal epithelium of healthy volunteers and contact lens wearers. Cornea 2007, 26:47-54.
19. Iskeleli G., Karakoç Y., Aydn Ö., Yetik H., Uslu H., Kzlkaya M. Comparison of tear-film osmolarity in different types of contact lenses. CLAO J 2002, 28:174-176.
20. Debbasch C., Brignole F., Pisella P.-J., Warnet J.-M., Rat P., Baudouin C. Quaternary ammoniums and other preservatives contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci 2001, 42:642-651.
21. Grus F.H., Kramann C., Bozkurt N., Wiegel N., Bruns K., Lackner N. Pfeiffer N Effects of multipurpose contact lens solutions on the protein composition of the tear film. Cont Lens Anterior Eye 2005, 28:103-112.
22. Heinämäki A.A., Muhonen A.S.H., Piha R.S. Taurine and other free amino acids in the retina, vitreous, lens iris-ciliary body and cornea of the rat eye. Neurochem Res 1986, 11:535-542.
23. Reddy D.V.N. Distribution of free ammo acids and related compounds in ocular fluids, lens, and plasma of various mammalian species. Invest Ophthalmol 1967, 6.
24. Reddy D.V.N. Distribution of free amino acids and related compounds in rabbit cornea. Ophthal Res 1970, 1:48-57.
25. Gupta K., Mathur R.L. Distribution of Taurine in the crystalline lens of vertebrate species and in cataractogenesis. Eye Res 1983, 37:379-384.
26. Orr H.T., Cohen A.I., Lowry O.H. The distribution of taurine in the vertebrate retina. J Neurochem 1976, 26:609-611.
27. Voaden J., Lake N., Narshall J., Morjaria B. Studies on the distribution of Taurine and other neuroactive amino acids in the retina. Exp Eye Res 1977, 25:249-257.
28. 35S]Taurine in brain, retina, and other tissues. J Nutr 1978, 108:1462-1476.
29. Pow D.V., Sullivan R., Reye P., Hermanussen S. Localization of taurine transporters, taurine, and 3H taurine accumulation in the rat retina, pituitary, and brain. Glia 2002, 37:153-168.
30. Pescosolido N., Imperatrice B., Koverech A., Messano M. L-carnitine and short chain ester in tears from patients with dry eye. Optom Vis Sci 2009, 86:132-138.
31. Nakatsukasa M., Sotozono C., Shimbo K., Ono M., Miyano H., Okano A., et al. Amino acid profiles in human tear fluids analyzed by high-performance liquid chromatography and electrospray ionization tandem mass spectrometry. Am J Ophthalmol 2011, 151:799-808.
32. Lange R. The osmotic function of amino acids and Taurine in the mussel Mytilus edulis. Comp Biochem Physiol 1963, 10:173-179.
33. Arakawa T., Timasheff S.N. The stabilization of proteins by osmolytes. Biophys J 1985, 47:411-414.
34. Obrosova I.G., Minchenko A.G., Marineseu V., Fathallah L., Kennedy A., Stockert C.M., et al. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia 2001, 44:1102-1110.
35. Pasantes-Morales, Wright C.E., Gaull G.E. Taurine protection of lymphoblastoid cells from iron-ascorbate induced damage. Biochem Pharmacol 1985, 34:2205-2207.
36. Waterfield C.J., Mesquita M., Parnham A., Timbrell J.A. Cytoprotective effects of Taurine in isolated rat hepatocytes. Toxicol In Vitro 1994, 8:573-575.
37. Venkatesan N., Venkatesan P., Karthikeyan J., Arumugam V. Protection by Taurine against adriamycin-induced proteinuria and hyperlipidemia in rats. Proc Soc Exp Biol Med 1997, 215:158-164.
38. Saad S.Y., Al Rikabi A.C. Protection effects of taurine supplementation against cisplatin-induced nephrotoxicity in rats. Chemotherapy 2002, 48:42-48.
39. Nakamori K., Koyama I., Nakamura T., Nemoto M., Yoshida T., Umeda M., et al. Quantitative evaluation of the effectiveness of taurine in protecting the ocular surface against oxidant. Chem Pharm Bull(Tokyo) 1993, 41:335-338.
40. Endo Y., et al. Mechanisms of cytoprotective effect of amino acids on local toxicity caused by sodium laurate, a drug absorption enhancer, in intestinal epithelium. J Pharm Sci 2002, 9:730-743.
41. Dkhissi O., Chanut E., Wasowicz M., Savoldelli M., Nguyen-Legros J., Minvielle F., et al. Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder. Invest Ophthalmol Vis Sci 1999, 40:990-995.
42. Madl J.E., McIlnay T.R., Powell C.C., Gionfriddo J.R. Depletion of Taurine and glutamate from damaged photoreceptors in the retinas of dogs with primary glaucoma. Am J Vet Res 2005, 66:791-799.
43. Pasantes Morales H., Quiroz H., Quesada O. Treatment with Taurine, Diltiazem, and Vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year follow-up study. Metab Brain Dis 2002, 17:183-197.
44. Malone J.I., Lowitt S., Cook W.R. Nonosmotic diabetic cataracts. Pediatr Res 1990, 27:293-296.
45. Berson E.L., Schmidt S.Y., Rabin A.R. Plasma amino-acids in hereditary retinal disease. Ornithine, Lysine, and Taurine. Br J Ophthalmol 1976, 60:142-147.
46. ChenZhuo L., Murube J., Latorre A., del Río R.M. Different concentrations of amino acids in tears of normal and human dry eyes. Adv Exp Med Biol 2002, 506:617-621.
47. Puck A., Liappis N., Hildenbrand G. Ion exchange column chromatographic investigation of free amino acids in tears of healthy adults. Ophthal Res 1984, 16:284-288.
48. Schuller-Levis G.B., Park E. Taurine: new implications for an old amino acid. FEMS Microbiol Lett 2003, 226:195-202.
49. Gupta R.C., Win T., Bittner S. Taurine analogues; a new class of therapeutics: retrospect and prospects. Curr Med Chem 2005, 12:2021-2039.
50. Shevchenko A., Tomas H., Havlis J., Olsen J.V., Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 2006, 1:2856-2860.
51. Tschoerner F., Boehm N., Kroll P., Blindert M., Pfeiffer N., Grus F.H. Proteomics Pipeline Mainz (P2M) and profiling of mass spectrometry data 2008, HUPO Annual World Congress, Amsterdam, Netherlands.
52. de Souza G.A., Godoy L.M.F., Mann M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol 2006, 7:R72.
53. Li N., Wang N., Zheng J., Liu X.M., Lever O.W., Erickson P.M., et al. Characterization of human tear proteome using multiple proteomic analysis techniques. J Proteome Res 2005, 4:2052-2061.
54. Zhou L., Beuerman R.W., Foo Y., Liu S., Ang L.P.K., Tan D.T.H. Characterisation of human tear proteins using high-resolution mass spectrometry. Ann Acad Med Singapore 2006, 35:400-407.
55. Green-Church K.B., Nichols K.K., Kleinholz N.M., Zhang L., Nichols J.J. Investigation of the human tear film proteome using multiple proteomic approaches. Mol Vis 2008, 14:456-470.
56. Cojocaru V.M., Ciurtin C., Uyy E., Antohe F. Nano-LC mass spectrometry proteomic tear secretion analysis in patients with secondary Sjögren's syndrome. Dig J Nanomater Bios 2011, 6:507-514.
57. Yang M., Fazio S., Munch D., Drumm P. Impact of methanol and acetonitrile on separations based on π-π interactions with a reversed-phase phenyl column. J Chromatogr 2005, 1097:124-129.
58. Shen D., Pan M.-H., Wu Q.-L., Park C.-H., Juliani H.R., Ho C.T., et al. LC-MS method for the simultaneous quantitation of the anti-inflammatory constituents in Oregano (Origanum species). J Agric Food Chem 2010, 58:7119-7125.
59. Nakano T., Ozimek L. Purification of glycomacropeptide from non-dialyzable fraction of sweet whey by hydrophobic interaction chromatography on phenyl-agarose. Biotechnol Lett 2000, 22:413-416.
60. Fernandez J., Mische S.M. Enzymatic digestion of membrane-bound proteins for peptide mapping and internal sequence analysis. The Protein Protocols Handbook 2002, Humana Press Inc. 2nd edition. J.M. Walker (Ed.).
61. Granvogl B., Plöscher M., Eichacker L.A. Sample preparation by in-gel digestion for mass spectrometry-based proteomics. Anal Bioanal Chem 2007, 389:991-1002.
62. Bodnar W.M., Blackburn R.K., Krise J.M., Moseley M.A. Exploiting the complementary nature of LC/MALDI/MS/MS and LC/ESI/MS/MS for increased proteome coverage. J Am Soc Mass Spectrom 2003, 14:971-979.
63. Stapels M.D., Barowsky D.F. Complementary use of MALDI and ESI for the HPLC-MS/MS analysis of DNA-binding proteins. Anal Chem 2004, 76:5423-5430.
64. Yang Y., Zhang S., Howe K., Wilson D.B., Moser F., Irwin D., et al. A Comparison of nLC-ESI-MS/MS and nLC-MALDI-MS/MS for GeLC-based protein identification and iTRAQ-based shotgun quantitative proteomics. J Biomol Tech 2007, 18:226-237.
65. Ng V., Cho P., Mak S., Lee A. Variability of tear protein levels in normal young adults: between-day variation. Graefes Arch Clin Exp Ophthalmol 2000, 238:892-899.
66. Ng V., Cho P., Wong F., Chan Y. Variability of tear protein levels in normal young adults: diurnal (daytime) variation. Graefes Arch Clin Exp Ophthalmol 2001, 239:257-263.
67. Lam T.C., Chun R.K.M., Li K.-K., To C.-H. Application of proteomic technology in eye research: a mini review. Clin Exp Optom 2008, 1:23-33.
68. Mukherjee A.B., Zhang Z., Chilton B.S. Uteroglobin: a steroid-inducible immunomodulatory protein that founded the Secretoglobin superfamily. Nedcor Rev 2007, 28:707-725.
69. Laurie G.A.W.K., Olsakovsky L.A., Conway B.P., McKown R.L., Kitagawa K., Nichols J.J. Dry eye and designer ophthalmic. Optom Vis Sci 2008, 85:1-18.
70. Cejkova J., Lojda Z., Vacik J., Digenis G.A., Dropcova S. Histochemical changes in the rabbit cornea and plasmin activity in the tear fluid during contact lens wear: favorable influence of protease inhibitors (aprotinin, PC5, elastatinal). Histochemistry 1992, 97:69-76.
71. Sack R., Tan K.O., Tan A. Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest Ophthalmol Vis Sci 1992, 33:626-640.
72. Willcox M.D.P., Morris C.A., Thakur A., Sack R.A., Wickson J., Boey W. Complement and complement regulatory proteins in human tears. Invest Ophthalmol Vis Sci 1997, 38:1-8.
73. Yamamoto G.K., Allansmith M.R. Complement in tears from normal humans. Am J Ophthalmol 1979, 88:758-763.
74. Mondino B.J., Zaidman G.W. Hemolytic complement in tears. Ophthalmic Res 1983, 15:208-211.
75. Chen W., Lu H., Dutt K., Smith A., Hunt M., Hunt R. Expression of the protective proteins hemopexin and haptoglobin by cells of the neural retina. Exp Eye Res 1998, 67:83-93.
76. Dobryszycka W. Biological functions of haptoglobin - new pieces to an old puzzle. Eur J Clin Chem Clin Biochem 1997, 35:647-654.
77. Karring H., Thøgersen I.B., Klintworth G.K., Møller-Pedersen T., Enghild J.J. The human cornea proteome: bioinformatic analyses indicate import of plasma proteins into the cornea. Mol Vis 2006, 12:451-460.
78. Nielsen M.J., Petersen S.V., Jacobsen C., Oxvig C., Rees D., Møller H.J., et al. Haptoglobin-related protein is a high-affinity hemoglobin-binding plasma protein. Blood 2006, 108:2846-2849.
79. Shioda R., Reinach P.S., Hisatsune T., Miyamoto Y. Osmosensitive taurine transporter expression and activity in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2002, 43:2916-2922.
80. Ito T., Fujio Y., Hirata M., Takatani T., Matsuda T., Muraoka S., et al. Expression of taurine transporter is regulated through the TonE (tonicity responsive element)/TonEBP (TonE binding protein) pathway and contributes to cytoprotection in HepG2 cells. Biochem J 2004, 382:177-182.
81. Wersinger C., Lelong-Rebel I.H., Rebel G. Sensitivity of taurine uptake to oxygen-derived reactive substances in MDR and non-MDR cells. Amino Acids 2001, 21:91-117.
82. Wu G. Amino acids: metabolism, functions, and nutrition. Amino Acids 2009, 37:1-17.
83. Jäger K., Bönisch U., Risch M., Worlitzsch D., Paulsen F. Detection and regulation of cationic amino acid transporters in healthy and diseased ocular surface. Invest Ophthalmol Vis Sci 2009, 50:1112-1121.